ProfileGDS5822 / ILMN_1253761
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 77% 72% 68% 75% 72% 73% 72% 74% 70% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1102.477
GSM1276600PDAC Late Ablation Control 268.272
GSM1276601PDAC Late Ablation Control 359.468
GSM1276602PDAC Late Ablation 180.275
GSM1276603PDAC Late Ablation 264.672
GSM1276604PDAC Late Ablation 380.973
GSM1303940PDAC Late Ablation_anti-CTLA4 15572
GSM1303941PDAC Late Ablation_anti-CTLA4 2102.574
GSM1303942PDAC Late Ablation_anti-CTLA4 371.370